Chennai-based TAKE Solutions Ltd, a business technology company focused on life sciences and supply chain management, has agreed to acquire two US-based companies operating in the life sciences space, it said in a stock-exchange disclosure. TAKE Solutions is buying health research firm KAI Research for $27 million (around Rs 190 crore) and clinical research and functional service provider DataCeutics for $45 million (about Rs 317 crore), both in cash. The acquisition of KAI will strengthen TAKE's therapeutic expertise in mental health, musculoskeletal diseases, neurology, infectious diseases, oncology and medical devices. TAKE will also acquire Phase II and Ill capabilities in North America adding to its current service offerings in Europe and Asia. The acquisition of DataCeutics will strengthen TAKE's data science capabilities, particularly in life sciences and will boost its presence in the US. TAKE will absorb DataCeutics's team. TAKE will complete its acquisition of KAI by the end of this month and that of DataCeutics by the end of February.